|
|
 |
|
Viewing report
|
|
|
|
Pharmaceutical Project and Portfolio Management: Effective Organization and Decision-Making For Long-Term Growth
Business Insights, June 2005
Pharmaceutical companies operate in multi-project, multi-product environments: the challenge facing pharmaceutical executives is to determine which projects - each potentially having a strong value proposition and being championed by different business units - should receive investment. Portfolio management aims to meet the challenges of operating in a multi-project/product environment by determining the optimal mix of projects and products within a portfolio.
Pharmaceutical Project and Portfolio Management: Effective organization and decision-making for long-term growth, is a strategic management report which provides expert analysis on budget and resource allocation decision-making, enabling you to convert promising product portfolios into highly profitable revenue streams. Recent trends in increased R&D spend and falling productivity levels have put increased pressure on managing the portfolio in order to maximize returns. Effective portfolio management will steer pharmaceutical companies through periods of slow growth and deliver shareholder confidence in future growth.
Key Questions answered in this report
- What are the main drivers of project and portfolio management in the pharmaceutical industry?
- What are current best practices in portfolio management processes?
- How do the various approaches to project evaluation differ?
- How can I apply evaluation techniques to my projects?
- Which project management strategies are leading companies using?
- Which portfolio management strategies are leading companies using?
- How can internal and external portfolios be combined?
- How can new portfolio management processes be developed and implemented?
Benefits of the report:
- Implement effective project and portfolio management processes in your company by reviewing worked examples of project evaluation techniques.
- Identify current industry best practices and benchmark your performance against leading pharmaceutical and biotechnology companies with portfolio management case studies from Novartis, GlaxoSmithKline, Genentech, Bristol-Myers Squibb and Aventis.
- Prepare for current and future industry trends set to influence existing processes by reviewing key contextual settings for portfolio management.
- Assess recommendations for effective portfolio management at corporate, R&D and marketing levels and make immediate improvements to your current processes.
- Develop a long term portfolio management strategy by analyzing opinions from portfolio management experts and implementing an optimal process which stops you pursuing unsuccessful pharmaceutical projects.
Customers who bought this item also bought
Pharmaceutical Portfolio Management: Strategies to Deliver Corporate Success
Optimizing Portfolio Management: Strategies to Deliver Corporate Success
Pharmaceutical Portfolio Management Strategy
Trends in Pharmaceutical Portfolio Management - Strategies to maintain profitability despite adversity
Active Credit Portfolio Management in Practice
Portfolio Management
The Wiley Guide to Project, Program, and Portfolio Management
Transportation Decision Making: Principles of Project Evaluation and Programming
The 2009-2014 World Outlook for Project and Portfolio (PPM) Management Software
The 2009-2014 Outlook for Project and Portfolio (PPM) Management Software in Latin America
The 2009-2014 Outlook for Project and Portfolio (PPM) Management Software in Asia
The 2009-2014 Outlook for Project and Portfolio (PPM) Management Software in Europe
|
|
|
|
